References
- Arora, P., Mukherjee, B. (2002). Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 91:2076–89.
- Asher, M.I., Montefort, S., Bjorksten, B., Lai, C.K., Strachan, D.P., Weiland, S.K., Williams, H. (2006). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lance. 368:733–43.
- Cochrane M.G., Bala, M.V., Downs, K.E., Mauskopf, J., Ben-Joseph, R.H. (2000). Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest. 117:542–50.
- Cui, Y., Frank, S.G. (2006). Characterization of supersaturated lidocain/polyacrylate pressure sensitive systems:thermal analysisi and FT-IR. J Pharm Sci. 95:701–13
- Hadgraft, J. (1999). Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm. 184:1–6.
- Ji, W., Chen, X., Zhengrong, C., Yumin, H., Huang, L., Qiu Y. (2008). Therapeutic effects of anti-B7-1 antibody in an ovalbumin-induced mouse asthma model. Int Immunopharmacol. 8:1190–5.
- Kakubari, I., Shinkai, N., Kawakami, J., Uruno, A., Takayasu, T., Yamauchi, H. (2006). Formulation and evaluation of ethylene-vinyl acetate copolymer matrix patches containing formoterol fumarate. Biol Pharm Bull. 29:513–6.
- Larrucea, E., Arellano, A., Santoyo, S., Ygartua, P. (2001). Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. Eur J Pharm Biopharm. 52:113–9.
- Lee, C.M., Chang, J.H., Moon, D.O., Choi, Y.H., Choi, I.W., Park, Y.M., Kim, G.Y. (2008). Lycopene suppresses ovalbumin-induced airway inflammation in a murine model of asthma. Biochem Biophys Res Commun. 374:248–52.
- Levison, K., Takayama, K., Isowa, K., Okabe, K., Nagai, T. (1994). Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J Pharm Sci. 83:1367–72.
- Manikandan, S., Devi, R.S. (2005). Antioxidant property of α-asarone against noise-stress-induced changes in different regions of rat brain. Pharmacol Res. 52:467–74.
- Merkle, H.P. (1989). Transdermal delivery systems. Methods Find Exp Clin Pharmacol. 11:135–53.
- O’Byrne, P.M., Inman, M.D. (2000). New considerations about measuring airway hyperresponsiveness. J Asthma. 37:293–302.
- Wu, Y. (2003). Study on the bioavailability of α-asarone tablets. China Clin Hosp Pharm J. 23:597–8.
- Zhao, K., Singh, J. (1999). In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethaol. J Contr Rel. 62:359–66.